Project Grant R21AI193607
Award Date
7/15/25
Completion Date
6/30/27
Dollars Obligated
$438K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This Project Grant award from the National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) provides $442,470.00 to the University of California, Merced to investigate the role of regulatory T cells in controlling immune responses to Coccidioides infection, which causes Valley Fever. The research aims to define the mechanistic relationship between regulatory T cells and the body's ability to clear Coccidioides fungal infections, in order to improve diagnosis,...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $556,375 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the J. Craig Venter Institute, Inc. (JCVI) on July 23, 2025. The grant, titled "Identifying the Molecular Determinants of Thermoadaptation and Parasitic Growth of Histoplasma capsulatum", aims to sequence and assemble approximately 150 new clinical isolates of the fungal pathogen Histoplasma capsulatum. The goal is to identify...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $494,696 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The University of Texas Health Science Center at San Antonio (UTHSCSA). The grant will fund research to better understand the translational control mechanisms that allow the fungal pathogen Candida albicans to respond to host environmental stresses and undergo critical morphological changes that enable infection....
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $2,205,213 Project Grant under the Allergy and Infectious Diseases Research (CFDA 93.855) program to the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. The grant, titled "Deciphering Immunopathogenesis of Mucormycosis to Advance Risk Stratification, Diagnosis and Management of the Disease", aims to improve understanding of the immune response and pathogenesis of mucormycosis, a...
This federal Project Grant award of $616,588 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) will support research by The Regents of the University of California, San Francisco (UCSF) to exploit a high-precision phenotypic map to illuminate environmental sensing mechanisms of the fungal pathogen Cryptococcus neoformans, which causes fungal meningitis. The research aims to 1) dissect the function of new components of key...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $782,178 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Research Foundation for the State University of New York, doing business as Stony Brook University. The grant supports research to develop novel antifungal inhibitors targeting the sterylglucosidase enzymes SGL1 and SGLA, which are essential for the pathogenicity of the fungal pathogens Cryptococcus neoformans and...
This Project Grant award of $247,621.00 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund an exploratory study by The Leland Stanford Junior University to evaluate whether pesticides, particularly fungicides and rodenticides, are geographically and temporally linked to human coccidioidomycosis (Valley Fever) cases or the environmental presence of the causative fungus, Coccidioides, in...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $689,068 Project Grant under CFDA 93.855 Allergy and Infectious Diseases Research to the University of Cincinnati to establish ex vivo growth systems for the fungal genus Pneumocystis. The key objectives are to: 1) conduct metabolite profiling and flux balance analysis to identify critical nutrients for growth of the P. carinii surrogate in a cell-free culture system, and 2) develop rat and human alveolar organoids to...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $249,749 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The University of Iowa. The grant supports research to develop a new approach for analyzing the transcriptional control of virulence in the fungal pathogen Aspergillus fumigatus, a leading cause of life-threatening infections in immunocompromised patients. The research aims to express a nanobody-E3 ligase fusion protein...
The University of Southern California (USC) received a $623,986 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) program. The funding supports a research project to study the genetic and molecular mechanisms that enable fungi, specifically the opportunistic pathogen Saccharomyces cerevisiae, to persist and cause infections in mammalian hosts. Key objectives include: Identifying causal...